Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection

Abstract Background Reducing LDL cholesterol (LDL-C) with statin-based therapy reduces the risk of major atherosclerotic events among patients with chronic kidney disease (CKD), with no evidence of an excess risk of cancer or death from any non-vascular cause. However, non-randomized data have sugge...

Full description

Bibliographic Details
Main Authors: C. Reith, N. Staplin, W. G. Herrington, W. Stevens, J. Emberson, R. Haynes, M. Mafham, J. Armitage, A. Cass, J. C. Craig, L. Jiang, T. Pedersen, C. Baigent, M. J. Landray, on behalf of the SHARP Collaborative Group
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Nephrology
Subjects:
Chronic Kidney Disease
Simvastatin
Statin Therapy
Ezetimibe
Albumin Creatinine Ratio
Online Access:http://link.springer.com/article/10.1186/s12882-017-0545-2

Internet

http://link.springer.com/article/10.1186/s12882-017-0545-2

Similar Items